Hydromer Partners With Avem to Expand Medical Coating Access Across Europe and UK
TL;DR
Hydromer's partnership with Avem gives medical device developers a competitive edge by providing faster access to advanced coating technologies that enhance device performance and reduce time to market.
The partnership combines Hydromer's coating platforms and R&D support with Avem's regional expertise to systematically help manufacturers scale from prototype to full production while navigating regulatory requirements.
This collaboration makes advanced medical coatings more accessible worldwide, potentially improving patient outcomes through better performing medical devices and accelerating healthcare innovation.
Hydromer's decades of coating expertise now connects directly with European medtech innovators through Avem, bringing specialized surface technologies to new medical device applications.
Found this article helpful?
Share it with your network and spread the knowledge!
Hydromer, Inc. has announced a new commercial partnership with Avem Market Solutions that will significantly expand access to its specialty medical coating technologies throughout Europe and the United Kingdom. The collaboration strengthens Hydromer's regional reach and technical support capabilities for medical device developers facing increasing pressure to innovate quickly while meeting strict regulatory requirements.
As Hydromer's strategic representative in the region, Avem will provide direct access to hydrophilic, lubricious, antimicrobial, and thrombo-resistant coating platforms along with custom formulation and R&D support for early development stages. The partnership also offers scalable coating equipment and tailored system design, supported by localized commercial guidance from a team deeply immersed in the EU and UK medtech ecosystems. This unified approach aims to help developers reduce time to market, enhance device performance, and streamline the transition from prototype to full-scale manufacturing.
The partnership brings together Hydromer's decades of experience in medical coatings with Avem's specialization in connecting Medtech OEMs and CDMOs with specialized suppliers. Avem, based in Galway, Ireland, focuses exclusively on the B2B medical technology sector, helping innovative contract design and manufacturing suppliers scale their commercial presence in European markets. View the original release on https://www.newmediawire.com.
Medical device manufacturers in Europe and the UK will benefit from earlier visibility into validated coating options, hands-on support for feasibility studies and scale-up, and a reliable resource for navigating technical and operational challenges. The collaboration provides a direct channel to explore coating technologies that have been proven in global markets, potentially eliminating barriers that often slow innovation in the highly regulated medical device industry.
This partnership arrives at a critical time when European medtech companies face mounting pressure to accelerate innovation while maintaining compliance with evolving regulatory standards. By combining Hydromer's technical capabilities with Avem's regional network and on-the-ground presence, the collaboration aims to make advanced coating solutions more accessible and easier to implement for device manufacturers at every stage of product development.
Curated from NewMediaWire
